Research programs of Clayton Foundation and its supporting organizations have led to several FDA approved drugs, medical devices and diagnostic assays along with the following pipeline in development by our licensees.
Pipeline
- Overview
- Research Projects
- Technologies & Patents
- Products Brought to Market
- Pipeline
- Research Institutions
- Licensees
- Contact Us
Available for Licensing (Pre-Clinical & Early Stage)
Partnered (Pre-Clinical & Clinical)
Dengue Virus Vaccine
Indication: 4 serotype dengue vaccine
IND in preparation
Chikungunya Virus Vaccine
Indication: vaccine to chikungunya
IND enabling studies
Zika Virus Vaccine
Indication: vaccine to zika
IND enabling studies
RT-200
Indication: Type II Diabetes
Advanced Preclinical
RT-300
Indication: Congestive Heart Failure
Preclinical
RT-400
Indication: Acute decompensated heart failure
Preclinical
GrB-Fc-SD1
Indication: Mesotheliomas & Pancreatic Cancers
Preclinical
GrB-Fc-IT4
Indication: Breast and other solid tumors
Preclinical
GrB-Fc-VEGF
Indication: Wet AMD & Choroidal Neovascularization
Preclinical
JamC mAb
Indication: B Cell Lymphomas
Animal in vivo POC
Olfml3 mAb
Indication: Metastatic breast cancer
Animal in vivo POC
VT-101
Indication: Solid Tumors
Phase I
